The Business Times

Companies & Markets

The Business Times
Subscribe
Share on FacebookShare on TwitterView more
The Business Times
Create a free account with Business Times for seamless access across SPH Media products.
REGISTER
LOGIN

Companies & Markets

SUBSCRIBERS

Brokers' take

Published Mon, Oct 19, 2015 · 09:50 PM
Share this article.

Biosensors International Group | Hold

Oct 19 close: S$0.70

Target price: S$0.66

OCBC Investment Research, Oct 19

Biosensors International Group recently announced that the Leaders Free clinical trial has demonstrated superior safety and efficacy for BioFreedom compared with a bare-metal stent (BMS), therefore suggesting that BioFreedom has the potential to benefit patients who are at high risk of bleeding (HBR) and unable to tolerate a prolonged course of dual antiplatelet therapy (DAPT). Considered by management to be a breakthrough technology, the group will be focusing on expanding their geographical reach for BioFreedom, with full commercial launch in this financial year. We d…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Companies & Markets

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here